View Section: Price ratios
Ishita Drugs Statements
52
Ishita Drugs Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2023-09-30
%
74.813
100
54.112
75
20.701
25
—
0
6.569
7.9
17.497
20.8
3.204
4.2
-0.33
-0.2
1.7
2.2
4.574
6.3
1.1
1.5
3.474
4.8
1.163
2.987
2023-03-31
%
58.832
100
40.837
66.7
17.996
33.3
—
0
6.875
13.3
14.615
25.4
3.381
7.9
-0.484
-1.7
1.113
3.3
4.01
9.6
1.07
2.7
2.94
6.8
0.983
2.99
2022-09-30
%
61.891
100
44.688
72.9
17.203
27.1
—
0
5.96
10.6
14.259
23.4
2.944
3.7
-0.052
-0.06
0.892
1.9
3.784
5.5
0.95
1.4
2.834
4.1
0.948
2.99
View Section: Balance Sheet